Related references
Note: Only part of the references are listed.Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
Carrie A. Schinstock et al.
TRANSPLANTATION (2020)
Interleukin-6: A Masterplayer in the Cytokine Network
Peter Uciechowski et al.
ONCOLOGY (2020)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antibody-mediated rejection: New approaches in prevention and management
R. A. Montgomery et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation
Ergun Velidedeoglu et al.
TRANSPLANTATION (2018)
B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
Tanvi Arkatkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
J. Choi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
D. Viglietti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
A Phase I/II Trial of the Interleukin-6 Receptor Specific Humanized Monoclonal (Tocilizumab) plus Intravenous Immunoglobulin in Difficult to Desensitize Patients
Ashley A. Vo et al.
TRANSPLANTATION (2015)
Antibody-Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options
Miae Kim et al.
PHARMACOTHERAPY (2014)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
J. Sellares et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation
Danelle Eto et al.
PLOS ONE (2011)
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
G. Einecke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
The effects of IL-6 on CD4 T cell responses
Oliver Dienz et al.
CLINICAL IMMUNOLOGY (2009)
Rituximab therapy for acute humoral rejection after kidney transplantation
Stanislas Faguer et al.
TRANSPLANTATION (2007)
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients
RA Montgomery et al.
TRANSPLANTATION (2000)
Share Paper
